Great Valley Advisor Group, Inc. Moderna, Inc. Transaction History

Great Valley Advisor Group, Inc.

  • $3.84 Billion
  • Q3 2024

A detailed history of Great Valley Advisor Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 7,248 shares of MRNA stock, worth $267,088. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,248
Previous 7,343 1.29%
Holding current value
$267,088
Previous $871,000 44.43%
% of portfolio
0.01%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$63.64 - $125.14 $6,045 - $11,888
-95 Reduced 1.29%
7,248 $484,000
Q2 2024

Jul 16, 2024
SELL
$101.21 - $166.61 $63,863 - $105,130
-631 Reduced 7.91%
7,343 $871,000
Q1 2024

May 03, 2024
BUY
$85.37 - $115.44 $15,622 - $21,125
183 Added 2.35%
7,974 $849,000
Q4 2023

Feb 05, 2024
SELL
$69.51 - $104.43 $34,963 - $52,528
-503 Reduced 6.06%
7,791 $774,000
Q3 2023

Nov 06, 2023
SELL
$96.41 - $126.61 $39,238 - $51,530
-407 Reduced 4.68%
8,294 $856,000
Q2 2023

Aug 10, 2023
SELL
$118.5 - $160.53 $27,136 - $36,761
-229 Reduced 2.56%
8,701 $1.06 Million
Q1 2023

May 02, 2023
BUY
$135.66 - $197.02 $501,670 - $728,579
3,698 Added 70.68%
8,930 $1.37 Million
Q4 2022

Jan 31, 2023
BUY
$118.38 - $210.04 $329,806 - $585,171
2,786 Added 113.9%
5,232 $939,000
Q3 2022

Oct 21, 2022
SELL
$118.07 - $194.18 $202,371 - $332,824
-1,714 Reduced 41.2%
2,446 $289,000
Q2 2022

Jul 19, 2022
BUY
$117.13 - $176.59 $157,891 - $238,043
1,348 Added 47.94%
4,160 $595,000
Q1 2022

Apr 20, 2022
BUY
$126.46 - $235.05 $12,519 - $23,269
99 Added 3.65%
2,812 $490,000
Q4 2021

Feb 10, 2022
SELL
$225.82 - $368.51 $1.81 Million - $2.95 Million
-7,998 Reduced 74.67%
2,713 $695,000
Q3 2021

Oct 14, 2021
BUY
$221.9 - $484.47 $1.05 Million - $2.29 Million
4,734 Added 79.2%
10,711 $4.12 Million
Q2 2021

Jul 27, 2021
SELL
$129.91 - $234.98 $52,353 - $94,696
-403 Reduced 6.32%
5,977 $1.4 Million
Q1 2021

Apr 20, 2021
SELL
$109.18 - $185.98 $223,709 - $381,073
-2,049 Reduced 24.31%
6,380 $835,000
Q4 2020

Jan 29, 2021
SELL
$65.74 - $169.86 $51,342 - $132,660
-781 Reduced 8.48%
8,429 $881,000
Q3 2020

Oct 21, 2020
SELL
$54.34 - $94.85 $137,045 - $239,211
-2,522 Reduced 21.5%
9,210 $651,000
Q2 2020

Jul 31, 2020
SELL
$29.67 - $80.0 $19,137 - $51,600
-645 Reduced 5.21%
11,732 $753,000
Q1 2020

May 15, 2020
BUY
$17.78 - $31.58 $220,063 - $390,865
12,377 New
12,377 $370,000

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Great Valley Advisor Group, Inc. Portfolio

Follow Great Valley Advisor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email